Gordon Tsui News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hong Kong: New education advisory head named

Global investors swoop in on WuXi Biologics shares as owner trims stakes in worlds largest post-IPO disposals WuXi Biologics, China site. Photo: Handout WuXi Biologics (Cayman), a bellwether of China's pharmaceutical producers, kicked off 2021 this week with a record stock price that took its gains since its 2017 initial public offer to 14-fold. Nearly 142 million shares changed hands on Tuesday, almost triple the average daily transactions last year, led by a 2.5 per cent sell-down that formed part of the disposal programme by the company's controlling shareholder Biologics Holdings from 73...